ABIN362313
antibody from antibodies-online
Targeting: MAPK14
CSBP1, CSBP2, CSPB1, Mxi2, p38, PRKM14, PRKM15
Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN362313 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Mitogen-Activated Protein Kinase 14 (MAPK14) (pTyr182) antibody
- Antibody type
- Polyclonal
- Antigen
- Peptide sequence around phosphorylation site of pTyr182 (T-G-Y (p) -V-A) derived from Human P38 MAPK. Antibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates.
- Description
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Epitope
- pTyr182
- Isotype
- IgG
- Vial size
- 50 μL
- Concentration
- 1 mg/mL
- Storage
- Store at -20°C for long term preservation (recommended). Store at 4°C for short term use.
Submitted references Lidocaine attenuates proinflammatory cytokine production induced by extracellular adenosine triphosphate in cultured rat microglia.
Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/beta-catenin pathway.
Intracellular acidosis-activated p38 MAPK signaling and its essential role in cardiomyocyte hypoxic injury.
p38 mitogen-activated protein kinase inhibition increases cytokine release by macrophages in vitro and during infection in vivo.
Su D, Gu Y, Wang Z, Wang X
Anesthesia and analgesia 2010 Sep;111(3):768-74
Anesthesia and analgesia 2010 Sep;111(3):768-74
Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/beta-catenin pathway.
Chen RS, Song YM, Zhou ZY, Tong T, Li Y, Fu M, Guo XL, Dong LJ, He X, Qiao HX, Zhan QM, Li W
Oncogene 2009 Jan 29;28(4):599-609
Oncogene 2009 Jan 29;28(4):599-609
Intracellular acidosis-activated p38 MAPK signaling and its essential role in cardiomyocyte hypoxic injury.
Zheng M, Reynolds C, Jo SH, Wersto R, Han Q, Xiao RP
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005 Jan;19(1):109-11
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005 Jan;19(1):109-11
p38 mitogen-activated protein kinase inhibition increases cytokine release by macrophages in vitro and during infection in vivo.
van den Blink B, Juffermans NP, ten Hove T, Schultz MJ, van Deventer SJ, van der Poll T, Peppelenbosch MP
Journal of immunology (Baltimore, Md. : 1950) 2001 Jan 1;166(1):582-7
Journal of immunology (Baltimore, Md. : 1950) 2001 Jan 1;166(1):582-7
No comments: Submit comment
No validations: Submit validation data